Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data
Open Access
- 23 July 2013
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-6
Abstract
Introduction. Severe sepsis and septic shock are the primary causes of multiple organ dysfunction syndrome (MODS), which is the most frequent cause of death in intensive care unit patients. Many pro- and anti-inflammatory mediators, such as interleukin-6 (IL-6), play a strategic role in septic syndrome. Continuous renal replacement therapy (CRRT) removes in a nonselective way pro- and anti-inflammatory mediators.Objective. To investigate the effects of continuous venovenous hemofiltration (CVVH) as an immunomodulatory treatment of sepsis in a prospective clinical study.Methods. High flux hemofiltration (Qf = 60 ml/Kg/hr) was performed for 72 hr in thirteen critically ill patients suffering from severe sepsis or septic shock with acute renal failure (ARF). IL-6 gene expression was measured by real-time PCR analysis on RNA extracted from peripheral blood mononuclear cell before beginning of treatment (T0) and after 12, 24, 48, and 72 hours (T1–4).Results. Real-time PCR analysis demonstrated in twelve patients IL-6 mRNA reduction after 12 hours of treatment and a progressive increase after 24, 48, and 72 hours.Conclusions. We suggest that an immunomodulatory effect might exist during CVVH performed in critically ill patients with severe sepsis and septic shock. Our data show that the transcriptional activity of IL-6 increases during CVVH.Keywords
This publication has 26 references indexed in Scilit:
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007
- Hemofiltration and Immune Response in Severe SepsisJournal of Surgical Research, 2007
- Blood and Plasma Treatments: The Rationale of High-Volume Hemofiltration2007
- SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admissionIntensive Care Medicine, 2005
- SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort descriptionIntensive Care Medicine, 2005
- Extracorporeal Therapies in Non-Renal Disease: Treatment of Sepsis and the Peak Concentration HypothesisBlood Purification, 2004
- Effect of hemodiafiltration and sepsis on chemotaxis of granulocytes and the release of IL‐8 and IL‐10Acta Anaesthesiologica Scandinavica, 2002
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patientsCritical Care Medicine, 1993
- Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cellsKidney International, 1992